Back to Search Start Over

Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020.

Authors :
Taine M
Offredo L
Drouin J
Toubiana J
Weill A
Zureik M
Dray-Spira R
Source :
Frontiers in pediatrics [Front Pediatr] 2021 May 28; Vol. 9, pp. 666848. Date of Electronic Publication: 2021 May 28 (Print Publication: 2021).
Publication Year :
2021

Abstract

Objectives: To describe changes in the dispensation of 11 mandatory vaccines to infants in France during the COVID-19 pandemic in 2020, considering the priming doses and boosters separately. Methods: With data from the French national health database, all dispensations of priming doses and boosters of 11 mandatory vaccines [penta/hexavalent, measles mumps rubella (MMR), meningococcal conjugate type-C (Men-C-C), 13-valent pneumococcal conjugate (PCV13)] for infants ≤24 months old were aggregated by 4-week periods in 2020. Expected counts in 2020 were estimated according to counts in 2019 weighted by a ratio considering the level of vaccine dispensation before the pandemic onset in 2020. Relative differences (RDs) and their 95% confidence intervals (CIs) were computed to compare the observed and expected counts during the first and second lockdown and the period in between. Results: During the first 4 weeks of the first lockdown, as compared with the expected numbers, the observed priming dose counts substantially decreased [RD: from -5.7% (95% CI -6.1; -5.2) for penta/hexavalent to -25.2% (95% CI -25.6; -24.8) for MMR], as did the booster counts [RD: from -15.3% (95% CI -15.9; -14.7) for penta/hexavalent to -20.7% (95% CI -21.3; -20.2) for Men-C-C]. Counts for priming doses and boosters remained slightly below the expected numbers after the lockdown. During 2020, MMR priming doses and the Men-C-C booster had the greatest shortfalls ( N = 84,893 and 72,500, respectively). Conclusions: This study provides evidence of a lack of vaccination catch-up after the first lockdown and a persistent shortfall in infant vaccination after the first 10 months of the COVID-19 pandemic in France, especially for the MMR priming doses and Men-C-C booster.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Taine, Offredo, Drouin, Toubiana, Weill, Zureik and Dray-Spira.)

Details

Language :
English
ISSN :
2296-2360
Volume :
9
Database :
MEDLINE
Journal :
Frontiers in pediatrics
Publication Type :
Academic Journal
Accession number :
34123969
Full Text :
https://doi.org/10.3389/fped.2021.666848